Discover Gene Therapy Insights - your portal to the cutting-edge world of gene therapy and precision medicine. Our mission is to gather and ignite novel insights that propel the field of genomic medicines forward. Join your host neurogeneticist Elena Buglo, PhD as we explore the growing spectrum of therapeutic targets for gene therapy, the challenges in clinical development, delivery, commercialization and the highlight the monumental breakthroughs with industry experts and thought leaders. Subscribe now for a journey into the future of medicine.
Gene Therapy Insights
Claim This Podcastby Elena Buglo
5.0(5 reviews)
5 episodes
Updated Weekly
Accepts GuestsHas Sponsors
Podcast Overview
Discover Gene Therapy Insights - your portal to the cutting-edge world of gene therapy and precision medicine. Our mission is to gather and ignite novel insights that propel the field of genomic medicines forward. Join your host neurogeneticist Elena Buglo, PhD as we explore the growing spectrum of therapeutic targets for gene therapy, the challenges in clinical development, delivery, commercialization and the highlight the monumental breakthroughs with industry experts and thought leaders. Subscribe now for a journey into the future of medicine.
Language
🇺🇲
Publishing Since
10/31/2023
1 verified contact email on file for Gene Therapy Insights
Pitch yourself as a guest, propose sponsorships, or reach out directly to the host.
Recent Episodes
April 25, 2024
Anti-aging gene therapies, non-viral approaches and disease as information with Matthew Scholz.
<p>Matthew Scholz is a serial entrepreneur with a background in computer science and immunology, bridging the best of the fields of physics, computing, genetics and medicine, he is on the forefront of anti-aging technologies and non-ordinary approaches to rare disease gene therapies.</p> <p><br></p> <p>Matt is a Chief Executive Officer and co-founder of Oisín Bio, a company focused on mitigating the senolytic technology to combat age-related diseases, With a gene delivery technology based on non-viral proteo-lipid vehicles. Matt is the founder of Immusoft, a biotech developing a breakthrough technology that turns a patient's B cells into miniature drug factories. He is a Co-Founder and Board Director of Sigma Genetics, Inc is building a non-invasive device that can deliver charged molecules, such as DNA, RNA, and proteins into patient cells. He is a CEO and Board Member, OncoSenX, Inc. (a developer of transient gene therapies designed for solid tumors). Lastly, he is a Co-Founder and Chief Technical Officer of Aegis Life, a company that works to protect human health from infectious diseases through Fusogenix technology.</p> <p><br></p> <p>In our conversation Matt shares his fascination with programming and immunology, especially the concept of immune memory and creation of the immune software, hence, Immusoft, where B cells are reprogrammed to become enzyme producing factories. Matt discusses the MPS1 program and the work it took to dose the first patient with this detrimental disease. </p> <p><br></p> <p>We lead the discussion into the information theory of aging, treating genetic disease as misinformation and hence, its correction. We touch on the transposon systems and the mysteries of retroviral DNA. </p> <p><br></p> <p>We then get into viral versus non viral approaches to gene therapy. You will be delighted to learn about the progress in follistatin gene therapy for enhancing muscle growth, senolytic gene therapy to tackle age related diseases and the continuous ever changing views that FDA takes on such uncharted territories. </p> <p><br></p> <p>We are thrilled to bring you this episode and we hope it amuses you with new and groundbreaking ideas!</p> <p><br></p> <p>As always, nothing on this podcast should be considered a medical advice, and opinions expressed are speakers' own.</p> <p><br></p> <p>Like and Subscribe to support us! Leave a comment with your questions and suggestions for the future episodes!</p>
February 13, 2024
Base Editing for Spinal Muscular Atrophy with Dr. Mandana Arbab
<p>In today's episode, we dive into the base editing approaches in Spinal Muscular Atrophy (SMA), a degenerative motor neuron disease caused by the loss of motor neurons in the spinal cord. </p> <p>Our guest is Dr. Mandana Arbab is the Lodish Family Assistant Professor of Neurology at Harvard Medical School and faculty member of the Rosamund Stone Zender Translational Neuroscience Center at Boston Children's Hospital. She received her Ph. D. in Regenerative Medicine at the Hubercht Institute in the Netherlands and completed her postdoctoral fellowship at the Broad Institute with Professor David Liu. </p> <p><br></p> <p>Dr. Arbab sheds light on the genetics of SMA, emphasizing the critical role of SMN genes and the potential of base editing to bring about transformative treatments. SMA stands out as the most common genetic cause of infant death worldwide, affecting patients within the first few months of life. The podcast delves into the existing therapeutics for SMA, such as antisense oligonucleotides and AAV gene therapy, examining their limitations and the quest for more precise and long-term solutions. The concept of base editing takes center stage, offering a promising approach to correct the genetic mutations associated with SMA.</p> <p><br></p> <p>Join us as we discuss the challenges and opportunities of bringing base editing into clinical trials. Learn about the intricacies of delivery mechanisms, biodistribution, and the potential for combining base editing with existing therapies. The conversation extends to considerations for clinical trials, including addressing off-target effects and the complexities of patient eligibility.</p> <p><br></p> <p>The podcast concludes with a glimpse into the future of CRISPR genome editing, and the exciting potential for transformative treatments in the realm of rare diseases.</p> <p><br></p> <p>Tune in to “Gene Therapy Insights” and embark on a journey through the cutting-edge world of gene therapy, where science meets hope, and the future of medicine unfolds.</p>
December 20, 2023
Energy Replacement in the Light of Aging with Dr. Shahaf Peleg
<p>Tune in to hear from Dr. <a href="https://www.linkedin.com/in/shahaf-peleg-72790263/" target="_blank" rel="noopener noreferer">Shahaf Peleg</a>, PhD, a co-founder of <a href="https://luminovabiotech.com/" target="_blank" rel="noopener noreferer">Luminova Biotech</a> and a researcher at the Research Institute for Farm Animal Biology as we explore the exciting work by the pioneers in the field of tackling age-related disorders with a light-activated energy replacement tool.</p> <p><br></p> <p>🔬 Join us as we explore the exciting work by the pioneers in the field, who are pushing the boundaries of science by converting light energy into mitochondrial chemical energy - MtON technology. It's not just a paradigm shift; it's a revolutionary way of thinking about human evolution as we face the disorders of aging.</p> <p><br></p> <p>🧬 Key topics explored:</p> <p>1️⃣ Discovery of a light-activated proton pump in fungi and exploration of its applications in humans</p> <p>2️⃣ Energy replacement and its place in mitochondrial dynamics</p> <p>3️⃣ Connection between epigenetics and metabolism in the pursuit of combating diseases of aging</p> <p>4️⃣ Comparisons to photobiomodulation as a mitochondrial biogenesis tool</p> <p>5️⃣ Considerations in the experimental design of a human gene therapy targeting local mitochondria for potential restoration of eyesight and beyond</p> <p><br></p> <p>👉 Your support matters! Like, share, subscribe, and review to help us bring you more thought-provoking episodes in the future.</p> <p><br></p> <p>👥 We value your engagement! Comment below or on your preferred platform with questions, guest suggestions, or topics you'd like us to explore.</p> <p><br></p> <p><strong>Disclaimer: Opinions expressed on this podcast are those of the speaker and are separate from any professional affiliations. Nothing on this podcast should be deemed as professional or medical advice.</strong></p> <p><br></p> <p>#BiotechInnovation #GeneTherapy #Optogenetics #MitochondrialScience #Agingscience #HealthcareRevolution #LuminovaBiotech #Longevity #ScienceExploration 🚀🔬</p>
5 total episodes available
Deep-dive analytics for Gene Therapy Insights
Frequently asked questions
Have a different question and can't find the answer you're looking for? Reach out to our support team by sending us an email and we'll get back to you as soon as we can.
- What is Gene Therapy Insights?
- How often does this podcast release new episodes?
This podcast updates weekly.
- Where can I listen to this podcast?
This podcast is available on 2 platforms including Apple Podcasts, Spotify, and more. You can also use the RSS feed directly.
- Does this podcast accept guests?
No, this podcast does not typically feature guests.
Legal Disclaimer
Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.
All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.
We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.
While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at hey@podengine.ai for prompt review and appropriate action, which may include content removal or proper attribution.
By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.